To better define the significance of proliferation centers (PCs), the morphological hallmark of chronic lymphocytic leukemia (CLL), lymph node biopsies taken from 183 patients were submitted to histopathologic and fluorescence in situ hybridization (FISH) studies using a 5-probe panel on tissue microarrays. Seventy-five cases (40.9%) with confluent PCs were classified as 'PCs-rich' and 108 cases (59.1%) with scattered PCs were classified as 'typical'. Complete FISH data were obtained in 101 cases (55.1%), 79 of which (78.2%) displayed at least one chromosomal aberration. The incidence of each aberration was: 13q- 36,7%, 14q32 translocations 30.8%, 11q- 24.7%, trisomy 12 19.5% and 17p- 15.6%. Five cases showed extra copies of the 14q32 regio...
Retrospective studies suggest cytogenetic abnormalities detected by interphase fluorescent in situ h...
The identification of the non-random genetic alterations associated with cancer has great importance...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
To better define the significance of proliferation centers (PCs), the morphological hallmark of chro...
Background. In chronic lymphocytic leukemia (CLL) molecular cytogenetic abnormalities may identify s...
In this study, we described cytogenetics and fluorescence in situ hybridization (FISH) analysis perf...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Clonal chromosome abnormalities can be detected in approximately 50% of patients with chronic lympho...
We examined copy number changes in the genomes of B cells from 58 patients with chronic lymphocytic ...
Chronic lymphocytic leukemia of B-cell type (CLL) is the most common disease entity of chronic leuke...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
Cytogenetic analysis of cells of chronic lymphocytic leukemia (CLL) is difficult because of their lo...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
In this study, we described cytogenetics and fluorescence in situ hybridization (FISH) analysis perf...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Retrospective studies suggest cytogenetic abnormalities detected by interphase fluorescent in situ h...
The identification of the non-random genetic alterations associated with cancer has great importance...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
To better define the significance of proliferation centers (PCs), the morphological hallmark of chro...
Background. In chronic lymphocytic leukemia (CLL) molecular cytogenetic abnormalities may identify s...
In this study, we described cytogenetics and fluorescence in situ hybridization (FISH) analysis perf...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Clonal chromosome abnormalities can be detected in approximately 50% of patients with chronic lympho...
We examined copy number changes in the genomes of B cells from 58 patients with chronic lymphocytic ...
Chronic lymphocytic leukemia of B-cell type (CLL) is the most common disease entity of chronic leuke...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
Cytogenetic analysis of cells of chronic lymphocytic leukemia (CLL) is difficult because of their lo...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
In this study, we described cytogenetics and fluorescence in situ hybridization (FISH) analysis perf...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Retrospective studies suggest cytogenetic abnormalities detected by interphase fluorescent in situ h...
The identification of the non-random genetic alterations associated with cancer has great importance...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...